Functional Decline After Multimodal Treatment of Oral Squamous Cell Carcinoma: A Prospective Longitudinal Study Using the Eastern Cooperative Oncology Group (ECOG) Scale.
- 1Oral and Maxillofacial Surgery, Dhaka Dental College and Hospital, Dhaka, BGD.
- 2Oral and Maxillofacial Surgery, Bangladesh Medical University, Dhaka, BGD.
Abstract
Background and aim Curative treatment of oral squamous cell carcinoma (OSCC) is often physically demanding, and the functional cost of therapy is not always reflected in oncological outcome measures alone. However, prospective evidence describing longitudinal changes in functional performance among patients undergoing curative treatment for OSCC, particularly in South Asian populations, remains limited. This prospective study aimed to evaluate longitudinal changes in Eastern Cooperative Oncology Group performance status among patients undergoing curative surgical treatment for OSCC. Specifically, Eastern Cooperative Oncology Group performance status (ECOG PS) was assessed before treatment, one month after surgery, and one month after completion of adjuvant therapy when indicated. This study also compared changes in performance status across treatment stages and explored clinical factors associated with functional deterioration. We hypothesized that multimodal treatment for OSCC would result in a significant decline in functional performance, with the magnitude of deterioration varying according to baseline performance status, treatment intensity, and reconstructive procedures. Methods In this longitudinal study conducted over one year (May 2024 to June 2025) at the Department of Oral and Maxillofacial Surgery, Bangladesh Medical University, we purposively enrolled 36 histopathologically confirmed OSCC patients undergoing curative surgery, with adjuvant therapy as indicated. ECOG PS was assessed by a semi-structured interview before treatment and one month after completion of surgery or, where applicable, one month after adjuvant therapy. We used paired-samples t-tests, Pearson correlations, and chi-square/unpaired Student's t-tests as appropriate (SPSS version 27.0 {Armonk, NY: IBM Corp.}; p<0.05 significant). Results Mean age was 55.6±10.7 years; 21 (58.3%) were female, and homemakers formed the largest single occupational group (n=20, 55.5%). A total of 15 patients (41.7%) had surgery alone, 13 (36.1%) had surgery plus radiotherapy, and eight (22.2%) had surgery plus chemoradiotherapy. Mean ECOG PS rose from 0.58±0.60 at baseline to 1.78±1.53 after treatment (mean change: +1.19±1.21; p<0.001). Deterioration occurred in 12 of 15 (80.0%) patients treated with surgery alone, eight of 13 (61.5%) patients receiving surgery plus radiotherapy, and seven of eight (87.5%) patients receiving surgery, radiotherapy, and chemotherapy. Higher baseline PS predicted greater absolute deterioration (R2=0.448 between pre- and post-treatment scores). Five patients (13.9%) died; both patients with baseline PS 2 died, compared with three of 34 patients with baseline PS 0-1. Score deterioration was most pronounced after reconstruction with distant free flaps (nine of 10 {90.0%} patients) and least pronounced after local flap reconstruction (three of seven {42.9%} patients). Conclusion Curative treatment of OSCC is associated with a clinically meaningful decline in functional performance status, disproportionately affecting patients who already present with impaired baseline status. Pre-treatment ECOG PS should be incorporated into shared decision-making and rehabilitation planning for OSCC patients.
Related
- Longitudinal Clinical and Functional Outcomes in Adult-Onset Delusional Disorder and Schizophrenia: A 10-Year Prospective Comparison Study
- Serial Casting as a Conservative Treatment for Adults With Upper Extremity Burn Contractures: A Prospective Longitudinal Study With a Criterion for Change
- Anthocyanin-Rich Freeze-Dried Berry Supplementation in Patients Undergoing Colorectal Cancer Treatment: A Prospective Single-Arm Pilot Study of Tolerability and Longitudinal Inflammatory Biomarker Changes
- Longitudinal dynamics of serum neurofilament light chain and prognostic value for functional outcome after acute stroke: a prospective cohort study.
- Reducing oral frailty improves functional independence in older Brazilians: a causal inference study of disability-free survival using longitudinal modified treatment policies
BibTeX
@article{saha2026functional,
title = {{Functional Decline After Multimodal Treatment of Oral Squamous Cell Carcinoma: A Prospective Longitudinal Study Using the Eastern Cooperative Oncology Group (ECOG) Scale.}},
author = {Chaiti Saha and Mahmudul Hasan and Ruman Banik and Ashik Abdullah Imon and Mohidul Islam and Md Asaduzzaman},
journal = {Cureus},
year = {2026},
month = oct,
doi = {10.7759/cureus.117648},
url = {https://europepmc.org/article/MED/42999909},
note = {CC BY},
}
RIS
TY - JOUR
TI - Functional Decline After Multimodal Treatment of Oral Squamous Cell Carcinoma: A Prospective Longitudinal Study Using the Eastern Cooperative Oncology Group (ECOG) Scale.
AU - Chaiti Saha
AU - Mahmudul Hasan
AU - Ruman Banik
AU - Ashik Abdullah Imon
AU - Mohidul Islam
AU - Md Asaduzzaman
PY - 2026
DA - 2026/10/08
JO - Cureus
DO - 10.7759/cureus.117648
UR - https://europepmc.org/article/MED/42999909
AB - Background and aim Curative treatment of oral squamous cell carcinoma (OSCC) is often physically demanding, and the functional cost of therapy is not always reflected in oncological outcome measures alone. However, prospective evidence describing longitudinal changes in functional performance among patients undergoing curative treatment for OSCC, particularly in South Asian populations, remains limited. This prospective study aimed to evaluate longitudinal changes in Eastern Cooperative Oncology Group performance status among patients undergoing curative surgical treatment for OSCC. Specifically, Eastern Cooperative Oncology Group performance status (ECOG PS) was assessed before treatment, one month after surgery, and one month after completion of adjuvant therapy when indicated. This study also compared changes in performance status across treatment stages and explored clinical factors associated with functional deterioration. We hypothesized that multimodal treatment for OSCC would result in a significant decline in functional performance, with the magnitude of deterioration varying according to baseline performance status, treatment intensity, and reconstructive procedures. Methods In this longitudinal study conducted over one year (May 2024 to June 2025) at the Department of Oral and Maxillofacial Surgery, Bangladesh Medical University, we purposively enrolled 36 histopathologically confirmed OSCC patients undergoing curative surgery, with adjuvant therapy as indicated. ECOG PS was assessed by a semi-structured interview before treatment and one month after completion of surgery or, where applicable, one month after adjuvant therapy. We used paired-samples t-tests, Pearson correlations, and chi-square/unpaired Student's t-tests as appropriate (SPSS version 27.0 {Armonk, NY: IBM Corp.}; p<0.05 significant). Results Mean age was 55.6±10.7 years; 21 (58.3%) were female, and homemakers formed the largest single occupational group (n=20, 55.5%). A total of 15 patients (41.7%) had surgery alone, 13 (36.1%) had surgery plus radiotherapy, and eight (22.2%) had surgery plus chemoradiotherapy. Mean ECOG PS rose from 0.58±0.60 at baseline to 1.78±1.53 after treatment (mean change: +1.19±1.21; p<0.001). Deterioration occurred in 12 of 15 (80.0%) patients treated with surgery alone, eight of 13 (61.5%) patients receiving surgery plus radiotherapy, and seven of eight (87.5%) patients receiving surgery, radiotherapy, and chemotherapy. Higher baseline PS predicted greater absolute deterioration (R2=0.448 between pre- and post-treatment scores). Five patients (13.9%) died; both patients with baseline PS 2 died, compared with three of 34 patients with baseline PS 0-1. Score deterioration was most pronounced after reconstruction with distant free flaps (nine of 10 {90.0%} patients) and least pronounced after local flap reconstruction (three of seven {42.9%} patients). Conclusion Curative treatment of OSCC is associated with a clinically meaningful decline in functional performance status, disproportionately affecting patients who already present with impaired baseline status. Pre-treatment ECOG PS should be incorporated into shared decision-making and rehabilitation planning for OSCC patients.
SN - 2168-8184
ER -